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1. Introduction 
Melanoma is a malignant tumor that results from DNA damage and related mutations in 
melanocytes (Rass & Reichrath, 2008). It usually occurs in result of collision of ultraviolet 
(UV) photon with a chromophore in a skin cell, production of reactive oxygen species which 
attack the melanocytes and induce oxidative stress with the DNA damage by oxidation. 
Conceptually, oxidative stress results from a change in the equilibrium between production 
of pro-oxidant and their consumption or deactivation, favoring an excess of pro-oxidant that 
have noxious consequences at the molecular and cellular levels (Ananthaswamy & Pierceall, 
1990). There are several mechanisms and barriers that protect the body against ultraviolet 
radiation: the stratum corneum, the outermost layer of the skin, and melanin pigment 
attenuate penetration of UV into the skin; antioxidative enzymes detoxify and metabolize 
reactive oxygen species; DNA repair systems protect cells from UV-induced lesions 
(Hoeijmakers, 2001). The cellular antioxidant defense relies to the great extent on a powerful 
sulfur redox chemistry response in which glutathione S-transferases are active players. 
Glutathione S-transferases (GSTs) comprise a multigene superfamily of enzymes that 
catalyze the conjugation of electrophilic toxic compounds with glutathione, playing a key 
role in phase II of detoxification (Hayes et al., 2005). GSTs are dimeric enzymes with subunit 
polypeptides organized into several cytosolic families (α, µ, π, σ, θ, ζ, ω) and one microsomal 
form (κ) (Frova, 2006). The human Pi class isoform of GSTs (GSTP1-1) is widely expressed in 
epithelial tissues and is the dominant isoform in lung, brain, skin, esophagus, erythrocytes 
and also in fetal tissues including liver, lung, kidney, and placenta (Moscow et al., 1989). 
This isoform has been proposed to be a caretaker gene, protecting cells against genome 
damage mediated by oxidants and electrophiles from inflammation or environmental 
exposure. Besides its typical role in detoxification of electrophilic toxic compounds this 
enzyme carries out a wide range of other functions, such as removal of reactive oxygen 
species and generation of S-thiolated proteins during the oxidative stress (Hayes & Strange, 
1995), binding and transfer of different ligands (Oakley et al., 1999), modulation of signaling 
pathways (Adler et al., 1999; Villafania et al., 2000; Wu et al., 2006; Zhao et al., 2006),  
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conjugation and transport of steroid hormones, dinitrosyl-diglutathionyl-iron complex 
storage and metabolism (De et al., 2003; Pedersen et al., 2007; Ricci et al., 2003; Turella et al., 
2003). 
The GSTP, GSTT and GSTM (GSTs) isoforms prevent carcinogenesis through inactivation of 
reactive electrophiles by conjugation to reduced glutathione. The human GSTP1 isoform 
also possesses selenium-independent peroxidase activity and restores organic hydro- and 
endoperoxides thus additionally protecting DNA from oxidative damage (Tan et al., 1988).  
Therefore, it is biologically plausible that a deficiency in the activity of GSTs may contribute 
to the risk of UV-induced melanoma. There are many evidences that mutation-associated 
reduction of GST activity predisposes to melanoma (Bu et al., 2007; Dolzan et al., 2006). 
However, mutations are not the single cause of GSTP1 insufficiency. This phenomenon 
occurs in different tumors as a result of GSTP1 gene repression by methylation of promoter 
or via specific set of transcription factors (Henderson et al., 1998).  
Unlike down-regulation of GSTP1 expression its overexpression is associated with the 
development of multidrug resistance (Harbottle et al., 2001). It is known that melanoma is 
the most aggressive form of skin cancer, which is notoriously resistant to all current 
modalities of anticancer therapy, including chemotherapy and γ-irradiation. Numerous 
genetic, functional and biochemical studies suggest that melanoma cells become insensitive 
to chemotherapeutic drugs by exploiting their resistance to apoptosis and by 
reprogramming their signaling pathways (Helmbach et al., 2001). It was demonstrated that 
GSTP1 and multidrug resistance protein 1 (MRP1) are overexpressed in multi-drug resistant 
melanoma cells and responsible for resistance to chemotherapy (Depeille et al., 2005).  
Thus, reactive oxygen species that damage melanocytes DNA, highly contribute to 
neoplastic transformation of melanocytes, what leads to the assumption that melanocytes 
should have reduced protection from electrophiles particularly due to reduced activity of 
corresponding detoxification enzymes. However, malignant melanoma is highly resistant to 
chemotherapy and γ-irradiation that points to the elevated detoxification and antioxidant 
activity in the tumor cells. This contradiction allowed us to suppose that activity of 
detoxification system, and particularly of GSTP1, may be down-regulated during neoplastic 
transformation, making the melanocytes sensitive to reactive oxygen species generated by 
UV-irradiation, and up-regulated by the therapeutic agents, conferring protection against 
them. To verify this assumption we decided to study the GSTP1 expression and its 
regulation at transcriptional level in human malignant melanoma cell line Me45 before and 
after Ǆ-irradiation. Due to the important role of GSTP1 in health and disease the regulation 
of GSTP1 gene expression is in the focus of interests of numerous researchers and clinicians, 
but according to our knowledge, the potential role of GSTP1 regulation in the etiology and 
the progress of melanoma were not studied before. Thereby we have addressed the 
following questions:  
- What is the level of GSTP1 expression in melanoma cells in comparison with the other 
malignant cell types and how does it change after Ǆ-irradiation; 
- Which cis-and trans-elements (transcription factors) participate in regulation of GSTP1 
transcription in melanoma cells;  
- Which transcription factors may contribute to induction of this gene in response to Ǆ-
irradiation. 
GSTP1 gene expression is regulated at transcriptional, post-transcriptional, translational and 
post-translational levels (Daniel, 1993; Jhaveri et al., 1997; Moffat et al., 1997). We focused 
our attention on the regulation at transcriptional level particularly by transcription factors 
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and cis-elements of the 5’-flanking region of the gene. Information about the structure of 
GSTP1 promoter and transcription factors that were reported to interact with specific sites is 
summarized in Fig.1.  
 
 
Fig. 1. Structure of the human GSTP1 gene 5’-regulatorey region and transcription factors 
known to interact with the promoter elements (Slonchak et al., 2009): (+) – positive 
regulation, (-) – negative regulation, (g) – general transcription factors 
The region spanning from – 80 to – 8 contains a TATA-box at – 28 to – 24, two Sp1 binding 
sites (G/C-boxes) located at – 43 to – 38 and – 53 to – 48 and antioxidant response element 
(ARE) at – 59 to – 66 (Cowell et al., 1988) and is essential for initiation of GSTP1 
transcription. Binding of Sp1 to the proximal G/C-box (Moffat et al., 1996a) and a 
transcription factor from AP-1 (Morrow et al., 1990) or NF-E2 family (Nishinaka et al., 2007) 
to ARE located in this minimal promoter are required to initiate the transcription. ARE is 
also responsible for gene induction by retinoic acid (Xia et al., 1996), estrogens (Montano et 
al., 2004), phorbol esters (Duvoix et al., 2004b), curcumin (Nishinaka et al., 2007) and 
doxorubicin (Duvoix et al., 2004a). The region spanning from – 1212 to – 90, which contains 
NF-κB-like element at – 98 to – 90 (Moffat et al., 1996b), NF-κB binding site at – 323 to  – 314 
(Morceau et al., 2004), cAMP response element (CRE) at – 512 to – 505 (Lo & li-Osman, 2002) 
and GATA-1 binding site at – 1212 to – 1207 (Morceau et al., 2000) is not essential for 
initiation of GSTP1 transcription but mediates gene’s responsibility to different stimuli. The 
NF-κB-like element mediates up-regulation of the GSTP1 gene transcription in response to 
oxidative stress by binding NF-κB (Xia et al., 1996) and transcription silencing  in MCF7 
breast cancer cells (Moffat et al., 1996b). NF-κB binding site was reported to bind NF-κB and 
stimulate gene expression in response to TNFǂ treatment in leukemia cells (Morceau et al., 
2004). CRE site binds CREB and mediates cAMP-dependent gene activation in lung cancer 
cells (Lo & li-Osman, 2002) and GATA-1 binds GATA-1 transcription factor and mediates 
the induction of GSTP1  transcription during hemin-induced differentiation of K562 cells  
(Schnekenburger et al., 2003).  
Despite the vast literature devoted to GSTP1 enzyme the functional characteristics of 
response elements in gene promoter and tissue-specific regulation of GSTP1 transcription 
are poorly understood and were not studied in melanoma cells. To fill this gap we 
performed the functional analysis of GSTP1 promoter in the human melanoma cell line. We 
examined GSTP1 expression level in these cells, the functional role of cis-elements in GSTP1 
promoter and identified transcription factors binding with these elements. We also 
conducted the experiments to analyze the ability of GSTP1 gene to be induced by Ǆ-
irradiation. 
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In this research we used cell line Me45, which is a human malignant melanoma cell line 
derived from a metastasis of skin melanoma into lymph node at 35 years old male. It was 
established in 1997 in the Department of Radiobiology of M. Sklodowska-Curie Cancer 
Centre and Institute of Oncology in Gliwice. Identity of melanoma cells was confirmed by 
immunocytochemical reaction with monoclonal antibodies to HMB50, S-100 and Melan A 
(Kumala et al., 2003; Przybyszewski et al., 2004; Rzeszowska-Wolny et al., 2009).  
2. Materials and methods 
2.1 Cell culture  
Human melanoma cells Me45, mammary carcinoma cells MCF7, epithelial breast cells Hbl-
100, bronchoalveolar carcinoma cells H358, alveolar carcinoma cells A549, erythroleukaemia 
cells K562, hepatocellular carcinoma cells HepG2, lung cancer cells Hct116, immortalized 
human bronchial epithelial cell BEAS2B, adrenal carcinoma cells FN-H296, mammary 
carcinoma cells MCF10A and choriocarcinoma cells BeWo were propagated in Dulbecco’s 
modified Eagle’s medium nutrient mixture F12 HAM (Sigma, USA) containing 12% fetal 
bovine serum (Gibco, USA) and 100 μg/ml gentamicine in tissue culture flasks. Culture 
medium for choriocarcinoma cells BeWo was also supplemented with MEM Non-Essential 
Amino Acid Solution 1x (MEM NEAA 100x, Gibco, USA). Incubation was performed at 
37 °C in humidified atmosphere of air containing 5% CO2.  
2.2 Ȗ-Irradiation of the cells  
Me45 and BeWo cells grown to 80% confluence in 3 cm culture dishes were Ǆ-irradiated at 1 
Gy/min from a Clinac 600 GMV (Varian, Palo Alto, CA, USA) at room temperature to a 
total dose of 2 Gy corresponding to therapeutic dose and then incubated at 37 °C during 
0.25-12 h. After incubation RNA was extracted from cells using RNA Mini kit (A&A 
Biotechnology, Poland). 
2.3 Estimation of GSTP1 expression  
2.3.1 RNA isolation and reverse transcription 
Total RNA was isolated from cultured cells grown to 80% confluence in 6-well plates using 
Total RNA Mini kit (A&A Biotechnology, Poland). RNA (1μg/lane) was analyzed by 
electrophoresis in denaturing agarose gel. First strand cDNA was synthesized from 1 μg of 
total RNA using iScriptcDNA Synthesis kit (Bio-Rad, USA). The 20 μl reaction contained 4ul 
5x iScript Reaction Mix, 1 μl iScriptReverce Transcriptase and 2 μg of total RNA. The 
reaction mixture was incubated 5 min at 25 °C, 30 min at 42 °C and 5 min at 85 °C. The 
resulted mixture was used directly for amplification by real-time PCR. 
2.3.2 Quantitative real-time PCR 
GSTP1 gene expression was determined by real-time PCR on DNA Engine Peltier Thermal 
Cycler with Chromo4 Real-Time PCR Detector (Bio-Rad, USA). PCR was performed in  
20 μl reaction mixture contained 2 μl cDNA, 10 μl 2x Real Time PCR Master Mix SYBR  
Set A (A&A Biotechnology, Poland) and 10 pmole of each primer - GSTP1L:  
5’-CCCAAGTTCCAGGACGGAGA-3’ and GSTP1R: 5’-GCCCGCCTCATAGTTGGTGT-3’. 
Samples were denatured at 94 °C for 4 min, and cDNA products were amplified with 45 
cycles of denaturation at 94 °C for 30 s, annealing at 60 °C for 30 s and extension at 72 °C for 
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30 s. The specificity of amplification was checked using post-PCR melting curves analysis. 
During exponential phase of PCR reaction, the crossing threshold (CT) was determined for 
each amplification curve. MCF10A cell line was used as calibrator. Results were normalized 
to RPL41 ribosomal protein mRNA quantified with qRT-PCR performed under the same 
conditions. The relative quatification ratio was determined based on CT method with an 
efficiency correction using Opticon Monitor 3 Software (Bio-Rad, USA). 
2.3.3 Semi-quantitative western blot analysis 
Cells grown to 80% confluence in 6-well plates were lysed in 500 μl of RIPA Buffer (Thermo 
Scientific, USA) supplemented with Complete Proteinase Inhibitor Cocktail (Roche, 
Switzerland). Protein concentration was determined using Bradford reagent (Bio-Rad, USA). 
Total proteins (25 μg) of each cell lysate were resolved in 12% SDS-PAGE according to 
Laemmli method (Laemmli, 1970), and electroblotted onto Immobilon-P Transfer Membrane 
(Millipore, USA). Immunodetection of GSTP1 protein was accomplished with rabbit 
polyclonal anti-GSTP1 antibody (StressGen, USA) diluted 1:1000 with 3% BSA in TBS 
following the procedure recommended by antibodies manufacturer. To detect the 
immunoreactive proteins, horseradish peroxidase-conjugated goat anti-rabbit IgG (Santa 
Cruz Biotechnology, USA) diluted 1:10000 with 3% BSA in TBS, and SuperSignal West Pico 
Chemiluminescent Substrate (Thermo Scientific, USA) was used. Visualization of the 
immunoreactive bands was achieved by exposing the membrane to the X-ray film. Films 
were developed and scanned. Band intensities were quantified with image analysis software 
GelPro 4.5 (Media cybernetics, USA). The amount of protein was normalized by Ponceau S 
staining of the membranes after electrotransfer. 
2.4 Analysis of functional activity of cis-elements in GSTP1 promoter and 
identification of transcription factors interacting with them 
2.4.1 Reporter constructs and transient transfection assay 
Fragments of GSTP1 gene promoter were prepared by PCR. The oligonucleotide 5’-
ACTCACTGGTGGCGAAGACT-3’ (position +15 to +35) was used as the downstream 
primer for all constructions. Each of the following oligonucleotides was used as the 
upstream primers to amplify promoter fragments: 5’-CAT AAA CAC CAA CCT CTT CCC 
C-3’ (position -1379 to -1357) for pGSTP1415, 5’-ATA GCC TAA GGC ACA GCC AC-3’ 
(position -1162 to -1142) for pGSTP1197, 5’-TTT CCT TTC CTC TAA GCG GC-3’ (position -
405 to -385) for pGSTP440, 5’-AGT CCG CGG GAC CCT CCA GA-3’ (position -105 to -85) 
for pGSTP140 and 5’-AGA GCG GCC GGC GCC GTG AC-3’ (position -85 to -64) for 
pGSTP120. Primers were designed by Vector NTI Advance 10.0 software (Invitrogen, USA) 
using GSTP1 gene sequence AY324387. PCR was performed in 25 μl of reaction mixture 
containing 1x QIAGEN PCR Buffer, 1.5 mM MgCl2, 200 μM each dNTP, 10 pmoles of each 
primer, 1x Q-solution, 500ng DNA and 2.5u Taq-DNA polymerase. DNA was denatured at 
94 °C for 10 min, and promoter fragments were amplified with 30 cycles -  denaturation at 
94 °C for 30 s, annealing and extension at 60 °C for 120 s (for 1415bp fragment), 90 s (for 1197 
bp fragment), 60 s (for 440 bp fragment) and 30 s (for 140 and 120 bp fragments). Final 
extension step was performed at 72 °C for 15 min. The amplified products were gel-purified 
using Gel-Out Kit (A&A Biotechnology, Poland) and subcloned into pCR2.1®-TOPO® 
vector (Invitrogen, USA), excised by KpnI and XhoI and religated into KpnI and XhoI 
linearized and dephosphorylated pGL3-basic plasmid (Promega, USA). DNA template for 
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PCR was isolated from human peripheral blood using Genomic Mini Kit (A&A 
Biotechnology, Poland). All PCR reagents and kits for plasmid isolation were obtained from 
Qiagen Inc. (USA). Plasmids for transfection were isolated using EndoFree Plasmid Maxi Kit 
(Qiagen Inc., USA). All enzymes were from MBI Fermentas (Lithuania). Sequences of 
relevant regions of the reporter constructs were confirmed by sequencing in both directions 
in OIigo.pl DNA IBB PAN Service (Poland). 
Me45 cells were grown in 24-well plates to 60% confluence and transfected with 500 ng of 
pGSTP together with 25 ng of pRL-TK plasmid (Promega, USA) per well using 
Lipofectamine™ LTX and PLUS™ reagents (Invitrogen, USA). After 20h the culture medium 
was removed, cells were washed with PBS and lysed in 250 μl of Passive lysis buffer 
(Promega, USA). Firefly and renilla luciferase activities were assessed in 5 μl of the lysates 
using Dual Luciferase® Reporter Assay System (Promega, USA). Light emission resulting 
from luciferase activity was measured in Lumat LB 9506 luminometer (Berthold technologies, 
USA) by integration of peak light emission during 10 s at 25 °C. The ratio between arbitrary 
firefly and renilla luciferase light units was calculated for each probe. Each experiment was 
repeated three times with triplications in each one. 
2.4.2 Electrophoretic mobility shift assay 
Me45 cells were grown in T225 flasks to 80% confluence. After removal of culture medium 
cells were washed with PBS, harvested, and nuclear extracts were prepared according to 
Dignam’s method (Dignam et al., 1983). A Bio-Rad Protein assay was used to determine 
protein concentration. 
The following oligonucleotides and their complementary sequences were used as probes in 
EMSA experiment: ARE (ARE site of human GSTP1 promoter) -  5’-CGC CGT GAC TCA 
GCA CTG GG-3’, NF-κB-like (NF-κB-like site of human GSTP1 promoter)  - 5’-TCC GCG 
GGA CCC TCC AGA AG-3’, NF-κB (NF-κB site of human GSTP1 promoter)  - 5’-CTT AGG 
GAA TTT CCC CCC GC-3’, CRE (CRE site of human GSTP1 promoter)  - 5’-GAG ACT ACG 
TCA TAA AAT AA-3’, GATA (GATA-1 binding site of human GSTP1 promoter) -  5’-GAG 
ATCA ATA TCT AGA AAT AA-3’. Probes were prepared by denaturation of complementary 
oligonucleotides for 2 min at 95 °C, annealing for 20 min at 60 °C and 30 min at 22 °C. 
Probes (10 pmoles) were incubated for 30 min with 20 pmoles [Ǆ-P32]-ATP 6000Ci/mmole 
(Hartmann Analytic, Germany) in 20 μl of reaction mixture containing  10 u PNK (Roche, 
Switzerland) and PNK Buffer. Unincorporated nucleotides were removed by gel-filtration 
through Bio-gel P-30 (Bio-Rad, USA). 
Five micrograms of cell nuclear extracts were preincubated for 10 min at 25 °C with 1ug 
sonicated E. coli DNA and with or without 5-10 pmoles of unlabeled competitor in 20 mM 
Tris-HCl pH 7.4, 150 mM NaCl, 1.5 mM MgCl2, 0.1 mM EDTA, 20% glycerol, 1 mM DTT. 
Then 0.1 pmole of [Ǆ-P32]-ATP labeled probe was added to the mixture and incubated for a 
further 30 min at 25 °C. The reaction mixture was then loaded onto a prerun (200 V for 1 h at 
4 °C) 6% native polyacrylamide gel (29:1 cross-linking ratio) containing 1x TBE. 
Electrophoresis was performed at 20 mA for 3h at 4 °C and the gel was then dried and 
radiographed. In supershift experiment the reaction mixture was preincubated for 20min at 
room temperature with 2 μg of antibody before the addition of radiolabeled probe. 
Consensus oligonucleotides for AP-1, NF-κB, CREB, GATA, ER and RAR, antibodies against 
human c-Jun (sc-44X crossreactive to JunB and JunD), c-Fos (sc-253X crossreactive to FosB 
and Fra2), MafF/G/K (sc-22831X), ERǃ (sc-8974X), Nrf3 (sc-15460X), NF-κB1 p50 (sc-1191X), 
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NF-κBRelA/p65 (sc-7151) and normal rabbit IgG (sc-2027) were from Santa Cruz 
Biotechnology, USA. 
3. Results 
3.1 Me-45 melanoma cells reveal low level of GSTP1expression 
At the first step of our study we examined GSTP1 expression in Me45 cells in comparison 
with the other malignant cells including breast cancer cells MCF7, nonmalignant breast cells 
Hbl-100, bronchoalveolar carcinoma cells H358, alveolar carcinoma cells A549, myelogenous 
leukaemia cells K562, hepatocarcinoma cells HepG2, colon cancer cells Hct116, immortalized 
human bronchial epithelial cell BEAS2B, adrenal carcinoma cells FN-H296, choriocarcinoma 
cells BeWo and mammary carcinoma cells MCF10A. We estimated the amount of GSTP1 
mRNA in total RNA isolated from these cells (Fig. 2). The level of GSTP1 mRNA in Me45 
cells was significantly lower than in majority of other cells and slightly higher than in BeWo 
cells. The GSTP1 mRNA content in MCF7 and HepG2 cells was below the level of detection.  
 
 
Fig. 2. Quantitative RT-PCR analysis of GSTP1 mRNA content in malignant cells (Slonchak 
et al, 2009). The values reflect the ratios of the normalized GSTP1 mRNA level in each cell 
type to the level in MCF10A cells that possess the highest GSTP1 expression. The data were 
normalized to expression of RPL41 ribosomal protein gene and represented as the mean ± SD 
of three separate experiments with triplications in each 
To verify whether the differences in GSTP1 mRNA content are persistent at the protein 
level, the semi-quantitative Western-blot analysis was undertaken. The GSTP1 protein 
content in Me45 cells was approximately 1.5-fold lower than in Hbl-100 cells and 1.9-fold 
higher than in BeWo cells (Fig. 3) that is compatible with the differences at mRNA level.  
3.2 GSTP1 expression in Me45 cells significantly elevates after Ȗ-irradiation 
The effect of ionizing radiation on GSTP1 expression in Me45 melanoma cells was assessed 
by determination of GSTP1 mRNA content in total cellular RNA before irradiation and at 
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0.25 h, 1 h, 3 h, 5 h, 8 h and 12 h thereafter (Fig. 4). It increased beginning from 0.25 h after 
irradiation and reached a nearly 5-fold increase at 8 h i.e. GSTP1 expression in Me45 cells is 
up-regulated by Ǆ-irradiation.  
 
 
Fig. 3. GSTP1 protein level in Hbl-100, Me45 aand BeWo cells. a) The ratios of densitometry 
densities of GSTP1 bands to the densities of the whole lane on Ponceau S-stained membrane 
are represented as the mean ± SD of three separate experiments with triplications in each;  
b) The representative immunoblot probed with antibodies to GSTP1; c) The membrane 
stained with Ponceau S as a loading control. The letters H, B and M designate Hbl-100, 
BeWo and M45 cells correspondingly 
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Fig. 4. Expression of GSTP1 gene in Me45 cells before and after Ǆ-irradiation. The values 
reflect the ratio of GSTP1 RNA in each time point to the value before irradiation. The data 
were normalized to content of RPL41 ribosomal protein mRNA and represented as the mean 
± SD of three separate experiments with triplications in each 
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3.3 Regions of GSTP1 promoter from – 1162 to – 405 and from – 105 to – 85 contain 
the negative regulatory elements and the region from – 405 to – 105 contains positive 
regulatory element in Me45 melanoma cells 
The regulatory role of different regions of GSTP1 promoter in Me45 cells was explored by 
transient transfection assay with the reporter constructs containing the firefly luciferase gene 
under the control of complete or truncated GSTP1 promoter. We designed the reporter 
constructs each lacking the DNA fragment containing one transcription factor binding site.  
Transfection of the vector pGSTP1415 containing the complete GSTP1 promoter (fragment 
from – 1379 to +35) resulted in relatively high level of f-luc gene expression (Fig. 5). Deletion 
of the flanking region from – 1379 to – 1162 with GATA-binding site did not change 
significantly the expression of the reporter gene. Further deletion of the region from – 1162 
to – 405 with CRE resulted in increase of f-luc expression approximately 1.8-fold in 
comparison with previous construct. Deletion of the next region (from – 405 to – 105) 
containing NF-κB binding site, diminished expression of the reporter gene approximately 
2.7-fold.  Deletion of the region from – 105 to – 85, known as NF-κB-like element, heightened 
the f-luc expression 1.9-fold.  
 
+35
+35
+35
+35
+35
pGSTP1415
pGSTP1197
pGSTP440
pGSTP140
pGSTP120
-1379
-1162
-405
-105
-85
0                               50                              100                            150                              200                            250                             300                             350
Relative Luciferase Activity, RLU
0,755342341
262,0243978
192,0929783
305,6790113
166,0000089
158,9263356
GATA CRE (ATAAA)n
CRE (ATAAA)n
NF-kB
   like
NF-kB
NF-kB NF-kB   like
NF-kB
   like
NF-kB NF-kB   like
pGL3-basic                F-Luc
ARE            Sp1           Sp1           TATA                           F-Luc
ARE            Sp1           Sp1           TATA                           F-Luc
ARE            Sp1           Sp1           TATA                           F-Luc
ARE            Sp1           Sp1           TATA                           F-Luc
ARE            Sp1           Sp1           TATA                           F-Luc
 
Fig. 5. Reporter constructs and relative luciferase activity in transfected Me45 cells. Data 
were normalized to expression of renilla luciferase from pRL-TK vector cotransfected 
together with the reporter constructs. Relative luciferase activity was calculated as a ratio of 
firefly to renilla luciferase light emission. Each bar in the figure represents the average ± SD 
of three independent transfection experiments with triplications in each 
Thus transient transfection experiment revealed two negative regulatory elements located in 
the regions from – 1162 to – 405 and from – 105 to – 85 and the strong positive regulatory 
element located in the region from – 405 to – 105 in GSTP1 promoter in Me45 cells. 
3.4 Nuclear proteins from Me45 cells specifically interact with ARE, NF-κB-binding 
site and CRE, but not with NF-κB-like and GATA sites 
To test the ability of the regulatory elements identified in GSTP1 promoter to interact with 
nuclear proteins from Me45 cells the electrophoretic mobility shift assay (EMSA) was 
performed. The ability of 20 bp promoter fragments, containing ARE, NF-κB-like, NF-κB, 
CRE and GATA sites to bind nuclear proteins from Me45 cells was examined in this 
experiment. Fig. 6 indicates that all oligonucleotides form complexes with Me45 nuclear 
proteins. 
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The specificity of protein binding was examined in a competition experiment, in which 
nuclear proteins were preincubated with 50- and 100-fold molar excess of unlabeled probe. 
This experiment demonstrated that CRE, NF-κB and ARE, but not NF-κB-like and GATA 
sites specifically bind nuclear proteins (Fig. 6B, C, Fig. 7). The complexes marked as non-
specific were not eliminated by excess of any unlabeled oligonucleotide identical to that 
used as a probe. 
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Fig. 6. In vitro binding of Me45 nuclear proteins to the GSTP1 promoter sites. Electrophoretic 
mobility shift assay demonstrates that Me45 nuclear proteins form complexes with ARE, 
NF-κB, NF-κB-like, CRE and GATA sites. Results of competitive EMSA demonstrate that 
protein binding to NF-κB-like and GATA site is nonspecific. S – specific complex, NS – non-
specific complex 
3.5 Transcription factor NF-κB, and ERȕ in complex with Fos or unidentified protein 
interact with GSTP1 promoter elements in Me-45 cells 
To identify the transcription factors that interact with GSTP1 promoter in Me45 cells we 
used a competitive EMSA with the oligonucleotides of two types - those containing consensus 
cis-elements to the potential transcription factors and authentic cis-elements (fig. 7). 
For identification of transcription factors that bind ARE site, a 50- and 100-fold molar excess 
of unlabeled oligonucleotides containing consensus binding sites for transcription factor AP-
1,  DNA-binding protein Maf (which mediates interaction of NF-E2 and related factors with 
DNA), estrogen receptor ǃ (ER ǃ) and retinoic acid receptor (RAR) were used. Neither of 
these consensus oligonucleotides competed for transcription factors with authentic ARE site 
(Fig. 7a). It means that DNA-binding domains of transcription factors that recognize 
consensus oligos do not interact with ARE site. This results were verified by supershift 
experiments with polyclonal antibodies to c-Jun (cross-reactive to JunB and JunD), c-Fos 
(cross-reactive to FosB, Fra1 and Fra2), MafF/G/K, ERǃ and Nrf3. As indicated in Fig. 7b, 
neither Jun, Fos nor Maf and Nrf3 transcription factors are involved in formation of specific 
complex with ARE site. However, antibody to ERǃ disrupted the original complex and the 
new complex with higher electrophoretic mobility was formed. Therefore it is plausible that 
ERǃ binds to the GSTP1 ARE site via another yet unidentified protein but not with its DNA-
binding domain.  
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                     (a)                                      (b)                                   (c)                          (d)                       (e)                         (f) 
Fig. 7. Analysis of the complexes formed by ARE, NF-κB and CRE sites of GSTP1 promoter 
with nuclear proteins. Formation of ARE-protein complex is inhibited by unlabeled authentic 
oligo with ARE site (a) and by ERǃ antibody (b); NF-κB-site forms two complexes, both 
disrupted by the authentic corresponding oligo and oligo with NF-κB consensus (c);  p50 
antibody supershifts both complexes and p65 antibody disrupts the upper complex (d); The 
complex of CRE site with nuclear proteins is inhibited by authentic oligo, oligos with AP-1 
consensus, but not CRE one compete with the CRE containing oligo (e); antibodies to Fos 
and ERǃ supershift the complex (f) 
The results of EMSA with oligonucleotide containing NF-κB site of GSTP1 are represented 
in Fig. 7c. Two specific complexes were detected in the reaction with nuclear proteins. The 
unlabeled oligo with NF-κB consensus efficiently competed with the authentic oligo 
containing NF-κB response element for the nuclear proteins involved in formation of upper 
and lower complexes (Fig. 7c).  
The composition of two different complexes with NF-κB response element was identified by 
supershift experiment with polyclonal antibodies to NF-κB1 p50 and RelA p65 subunits. 
Preincubation of nuclear proteins with antibody to p50 resulted in appearance of two 
supershifted bands (Fig. 7d). It means that both initial complexes contain p50 subunit of NF-
κB. In the presence of p65 antibody the upper band disappeared pointing to the 
involvement not only p50 but also p65 subunit in this complex. Hence we provided the 
evidence that p50/p50 homodimer and p50/p65 heterodimer interact with GSTP1 NF-κB 
binding site in Me45 cells. 
To test the ability of CRE site to interact with CREB and AP-1 proteins, the corresponding 
oligonucleotides containing consensus binding sites for both transcription factors were used 
in the competition experiments. An autoradiograph in Fig. 7e indicates that oligo with 
consensus sequence to CREB did not compete with authentic oligo, while cold authentic 
probe and oligo with consensus to AP-1 competed successfully. Therefore it means that 
transcription factor AP-1 binds to CRE in Me45 cells. 
The composition of CRE-protein complex was investigated by the supershift experiment 
with to Jun, Fos, MafF/G/K, ERǃ and Nrf3. Incubation with antibodies antibodies to Fos 
and ERǃ resulted in appearance of the new bands (Fig. 7f). Therefore both transcription 
factors take part in the complex formation with CRE in melanoma Me45 cells. 
Thus, we demonstrated that positive regulatory element ARE interacts with ERǃ in complex 
with another protein, negative regulatory element CRE  interacts with Fos/ERǃ-complex 
and positive regulatory element NF-κB binding site interacts with transcription factor NF-κB  
in the form of p50/p50 homodimer and  p50/p65 heterodimer. 
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3.6 Ȗ-Irradiation induces GSTP1 expression in melanoma cells Me45, but not in 
choriocarcinoma cells BeWo 
Transcription factor NF-κB (p65) is known to be activated during oxidative stress 
particularly that created by Ǆ-irradiation and hydrogen peroxide (Gilmore, 1999). Taking 
this fact into account we have supposed that p50/p65-heterodimer of NF-κB, identified as a 
part of DNA-protein complex formed on GSTP1 promoter in Me45 melanoma cells, may be 
responsible for GSTP1 induction by Ǆ-irradiation. To verify this assumption we used 
choriocarcinoma BeWo cells. The level of GSTP1 expression in BeWo cells is very near to 
that in Me45 cells as it was shown in this study (Fig. 2). But as we have demonstrated 
previously the p50/p65-heterodimer is not involved in regulation of GSTP1 transcription in 
BeWo cells while all other transcription factors are identical between two types of cells 
(Slonchak et al., 2009). As demonstrated in Fig. 8, GSTP1 mRNA content in BeWo cells in 
contrast to Me45 cells does not change significantly after γ-irradiation. It is quite possible 
that the sole difference between transcription factors regulating GSTP1 transcription in two 
types of cells, the presence/absence of p65 subunit of NF-κB, mediates induction of GSTP1 
transcription in response to Ǆ-irradiation in melanoma cells. 
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Fig. 8. Expression of GSTP1 gene in Me45 and BeWo cells before and after Ǆ-irradiation. 
Gray bars represent GSTP1 mRNA level in Me45 cells and white bars – in BeWo cells. The 
values were normalized to expression of RPL41 ribosomal protein gene and presented as the 
ratios to GSTP1 expression in both cells before irradiation. The graphs represent the mean 
data ± SD of three separate experiments with triplications in each 
4. Discussion 
GSTP1 is a caretaker gene as it detoxifies endogeneous and exogeneous toxic compounds 
and thus protects the organism against genome damage, oxidative stress (Hayes & Strange, 
1995), cancer (Henderson et al., 1998), and degenerative diseases (Guven et al., 2011). Down-
regulation of GSTP1 expression with concomitant decrease of detoxification is a common 
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precancerous event (Cookson et al., 1997; Meiers et al., 2007; Song et al., 2002) while its up-
regulation at the later stages of tumor development causes multidrug resistance (Diah et al., 
1999). The role of GSTP1 in development of malignant melanoma and its response to 
traditional therapy is far from being clear. 
Nowadays it is known that GSTP1 is expressed in normal human melanocytes and its 
expression is retained after malignant transformation (Hanada et al., 1991). Malignant 
melanocytes reveal resistance to the components of traditional therapy e.g. to etoposide, cis-
platinum, Ǆ-irradiation, which provoke the transition of the cells into apoptosis. In comparison 
with some other malignant cells (human leukemia cells HL-60, rat rhabdomyosarcoma cells 
R1) melanoma cells Me45 reveal greater resistance to each of these components and less 
quantity of cells are susceptible to apoptosis (Kumala et al., 2003). To unravel the potential 
role of GSTP1 in the malignant transformation of melanocytes and their resistance to 
traditional treatment we have focused our attention on the GSTP1 expression in malignant 
melanoma cells and molecular mechanisms of its regulation at transcriptional level. For this 
aim we examined the level of GSTP1 expression in malignant melanoma cells Me45 before 
and after Ǆ-irradiation and characterized cis-elements of GSTP1 promoter and transcription 
factors interacting with them.  
Among 12 malignant cell lines GSTP1 expression in Me45 cells was at the low level (the cells 
MCF7 and HepG2 do not express GSTP1 due to complete methlylation of GSTP1 promoter 
and potent repression of gene transcription). The situation drastically changes after  
Ǆ-irradiation. The Me45 and BeWo cells expressing GSTP1 nearly at the same level before 
irradiation significantly differ from one another after irradiation. The GSTP1 expression 
steadily rises in melanoma cells and remains at the same level in BeWo cells. It was known 
that GSTP1 may inhibit pro-apoptotic signal transduction (Zhao et al., 2006; Zhou et al., 
2005), conjugate etoposide to glutathione (Depeille et al., 2005) and by these ways protect 
the cells from apoptosis. Thereby the peculiarities of cell-specific regulation of GSTP1 
expression in melanocytes and its up-regulation after Ǆ-irradiation may to some extent explain 
the development of melanoma and its extreme resistance to chemo- and radiotherapy.   
Initiation of gene transcription in eukaryotes is a multistep process which includes chromatin 
remodeling, DNA demethylation, enchanseosome formation and the assembly of the 
general transcription machinery. Each event in this process is strictly controlled by cell- and 
state-specific coordinated interactions between transcription factors, coactivators and 
corepressors with chromatin and transcription machinery components. In this study we 
focused on the functional role of cis-elements of GSTP1 promoter and corresponding 
transcription factors in regulation of gene transcription in human malignant melanoma cells. 
The interaction of cis-elements of GSTP1 promoter with transcription factors were examined 
in different malignant cells (Duvoix et al., 2003; Henderson et al., 1998; Jhaveri & Morrow, 
1998). All these studies have shown that in different kind of cells cell-specific transcription 
factors bind the same response elements. So far the regulation of GSTP1 transcription in 
malignant melanocytes was not addressed. For the first time we have assessed the functional 
activity of GSTP1 cis-elements in malignant melanocytes and identified two elements - 
antioxidant response element (ARE) and NF-κB binding site, that positively regulate GSTP1 
transcription, and cAMP response element (CRE), that regulates it negatively. The same was 
true for mammary epidermal cells Hbl-100 and choriocarcinoma BeWo cells (Slonchak et al., 
2009). Therefore the different set of transcription factors may define either positive or 
negative regulation of GSTP1 transcription in cell-specific manner. 
In malignant melanocytes the positive regulatory element ARE interacts with ERǃ through 
another yet not identified protein. This fact distinguishes Me45 cells among other malignant 
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cells in which diverse transcription factors or in different way interact with this site. The 
diversity includes transcription factor AP-1 in breast cancer cells VCREMS (Moffat et al., 
1994) and in leukemia cells K562 (Duvoix et al., 2004a); transcription factor NF-E2 in K562 
cells (Borde-Chiche et al., 2001);  RARǂ  in HeLa cells (Xia et al., 1996) and ERǃ in complex 
with Jun/Fos or with Nuclear Factor E2 related factor (Nrf2) in mammary carcinoma cells 
MDA-MB-231(Montano et al., 2004). It is interesting that transcription factors Jun and Fos in 
the latter complex cannot activate GSTP1 transcription themselves but they recruit ERǃ and 
the whole complex substantially activates transcription and mediates up-regulation of 
GSTP1 expression by estradiol and antiestrogen tamoxifen (Montano et al., 2004).  
It is also noteworthy that in Me45 cells ERǃ indirectly interacts not only with antioxidant 
response element ARE, but also with cAMP response element CRE in complex with 
transcription factor Fos.  In GSTP1 promoter CRE was first identified in lung carcinoma cells 
Calu-6. In these cells it interacts with the transcription factor CREB-1 and mediates 
induction of GSTP1 transcription by cAMP (Lo & li-Osman, 2002). In contrast to this 
communication we demonstrated that in Me-45 cells CRE acts as a negative regulatory 
element. Thus in one type of cells CRE acts as a positive element interacting with CREB and 
in the other type of cells as a negative element directly interacting with Fos in complex with 
ERǃ. The similar phenomenon has been described for the gene encoding steroidogenic acute 
regulatory protein, which is up-regulated by CREB and down-regulated by Fos/Jun both 
interacting with CRE site (Manna & Stocco, 2007).   
The role of ERǃ in regulation of GSTP1 expression was a disputable question until now. 
Possible implication of ER into regulation of GSTP1 expression was demonstrated for the 
first time in 1988 by Moscow et al. who described the negative correlation between ER 
content and GSTP1 expression in breast cancer cells (Moscow et al., 1988). Later Montano et 
al. demonstrated that ERǃ acts as a positive regulator of GSTP1 expression in the same cells 
(Montano et al., 2004). Here we found that ERǃ indirectly interacts with two distinct sites of 
GSTP1 promoter - positive regulatory element ARE and a negative regulatory element CRE 
and in both cases different transcription factors mediate the effect of ERǃ.  We believe that 
these data may explain the previous contradictions - the ability of ERǃ to repress (Moscow 
et al., 1988) and induce (Montano et al., 2004) GSTP1 transcription. 
The region of GSTP1 promoter from – 405 to – 105 which contains NF-κB response element 
acts as a strong positive regulatory element in Me45 cells. It interacts with p50 NF-κB1/p65 
RelA heterodimer and with p50/p50 NF-κB1 homodimer in Me45 cells and only with 
p50/p50 NF-κB1 homodimers in BeWo cells (Slonchak et al., 2009). We suggest that 
activation of GSTP1 transcription in Me45 cells by γ-irradiation and the insensitivity of 
BeWo cells to the influence of irradiation are connected with the differences in NF-κB 
dimers in both types of cells. Proteins from NF-κB family may be subdivided into two 
classes according to the sequence of their C-terminal domain, presence of transcription 
activation domain (TAD) and the sequence specificity of response elements with which they 
interact.  Members of the class I (NF-κB1 p50 and NF-κB2 p52) do not contain TAD and have 
long C terminal domains with multiple copies of ankyrin repeats that inhibit the ability of 
the factors to activate transcription. The second class of NF-κB family includes c-Rel, v-Rel, 
RelB and RelA (p65). These proteins contain C-terminal activation domain TAD and can 
activate transcription (Schmid et al., 1994). The members of both classes in different 
combinations can form dimers with various regulatory potential. In different types of cells 
the homodimers Ȟ50/Ȟ50, Ȟ65/Ȟ65, ȟ-Rel/c-Rel and heterodimers RelB/p50, RelB/p52, 
p65/c-Rel, RelB/p65 Ƞа RelB/c-Rel were identified (Neumann & Naumann, 2007). 
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The members of the first class bind preferably to GGGRN motif in promoters (R – purine 
base, N – any base). The members of the second class bind to YYCC motif (Y – pyrimidine 
base). Thereby Ȟ50/Ȟ50 homodimers bind to 11 bp sequence which contains two GGGRN 
repeats, separated by А/Т-pair. The heterodimers consisting from the members of both 
classes bind GGRNWYYCC sequence (W – A or T) (Baldwin, Jr., 1996). The NF-κB binding 
site of GSTP1 promoter is GGGAATTTCCCC sequence and it corresponds to typical 
binding site for NF-κB heterodimers. The homodimers  Ȟ50/Ȟ50  may also interact with this 
site but this binding is weak and does not result in transcription activation (Neumann & 
Naumann, 2007). In this regard only the heterodimers containing either RelA, RelB or c-Rel 
with p50 or p52 are able to activate GSTP1 transcription. In this study we found that 
p50/p65 RelA NF-κB heterodimer and p50/p50 homodimer interact with NF-κB binding 
site of GSTP1 gene in Me45 cells in comparison with p50/p50 homodimers interacting with 
this site in BeWo cells. The obtained results together with the above mentioned 
characteristics of the members of both classes of NF-κB family explain very well the 
difference in response of Me45 and BeWo cells to γ-irradiation and the resistance of 
malignant melanoma cells to radiotherapy due to the activation of GSTP1 expression. The 
important role of p50/p65 RelA NF-κB heterodimer in this process is highly expected.  We 
have to note that Ǆ-irradiation causes degradation of NF-κB inhibitor with which it is bound 
in the cytoplasm and translocation of NF-κB into the nucleus with its subsequent 
participation in regulation of gene transcription. 
5. Conclusions 
Melanoma is a malignant tumor of melanocytes that occurs in result of collision of UV photon 
with a chromophore in a skin cell, production of reactive oxygen species and oxidative 
stress with the DNA damage. Conceptually, oxidative stress results from a change in the 
equilibrium between production of pro-oxidant and their consumption or deactivation, 
favoring an excess of pro-oxidant that have noxious consequences at the molecular and 
cellular levels. The cellular antioxidant defense relies to the great extent on a powerful sulfur 
redox chemistry response in which glutathione S-transferases are active players. Therefore a 
deficiency in the activity of GSTs may contribute to the risk of UV-induced melanoma.  
It is notorious that melanoma is the most aggressive form of skin cancer, which is resistant 
to all current modalities of anticancer therapy, including chemo- and radiotherapy. The 
overexpression of GST and multidrug resistance protein 1 may confer to the resistance of 
melanoma cells. 
We demonstrated that the level of GSTP1 expression in malignant melanoma cells Me45 was 
significantly lower than in eight other malignant cell lines and similar to that in 
choriocarcinoma cells BeWo. Despite the similarity of GSTP1 expression in nonirradiated 
Me45 and BeWo cells their response to Ǆ-irradiation was different - the level of GSTP1 
steadily rises merely in Me45 cells, not in BeWo cells. To find out the clue for the difference 
in response of both types of cells to Ǆ-irradiation we examined the regulation of GSTP1 gene 
transcription. Two cis-elements, ARE and NF-κB binding site, positively regulate GSTP1 
transcription, and element CRE regulates it negatively in Me45 cells. The same is true for 
BeWo cells as we have shown previously. In both types of cells cis-element ARE interacts 
with ERǃ through another yet not identified protein and cis-element CRE – with Fos/ERǃ 
dimer. However in Me45 cells NF-κB binding site interacts with p50/p65 RelA and p50/p50 
dimers of NF-κB while in BeWo cells – only with p50/p50 dimer. The induction of NF-κB in 
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response to Ǆ-irradiation, the strong activating potential of p65 RelA subunit of NF-κB and 
subsequent up-regulation of GSTP1 expression may stipulate the melanoma cells resistance 
to radiotherapy. However this cause may not be unique. 
According to our results Ǆ-irradiation induces activation of GSTP1 expression via 
transcription factor NF-κB.  Therefore we suggest that inactivation of NF-κB may prevent 
melanoma resistance. Clinical trials with drugs that block NF-κB are currently in progress 
with promising results. As reviewed by Lee and Burckart, the NF-κB activation process can 
be inhibited by pharmacologic agents at each activation step: glucocorticoids inhibit NF-κB 
by up regulating IKB expression, cyclosporine and tacrolimus inhibit calcineurin, a 
phosphatase that indirectly induces IKB degradation, deoxyspergualin inhibits nuclear 
translocation of NF-κB, aspirin and salicylates inhibit IKB phosphorylation, tepoxalin and 
antioxidants inhibit NF-κB activation by influencing the redox state of the cell (Lee & 
Burckart, 1998). It’s clear that development of specific inhibitory agents has to go in parallel 
with improvement of targeted drug delivery systems.   
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